NPTX2 is secreted by layer II neurons to promote AMPA receptor clustering at excitatory synapses. Early NPTX2 decline in AD leads to progressive AMPAR rundown, homeostatic downscaling, and compensatory NMDA-to-AMPA ratio increase that creates Ca²⁺ overload. Critically, an FDA-cleared CSF NPTX2 ELISA biomarker enables patient stratification and pharmacodynamic monitoring. Recombinant NPTX2 protein delivery via intranasal route is technically feasible.
No AI visual card yet
Dimension Scores
How to read this chart:
Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential.
The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength),
green shows moderate-weight factors (safety, competition), and
yellow shows supporting dimensions (data availability, reproducibility).
Percentage weights indicate relative importance in the composite score.
6 citations6 with PMIDValidation: 0%4 supporting / 2 opposing
✓For(4)
No supporting evidence
No opposing evidence
(2)Against✗
HighMediumLow
HighMediumLow
Evidence Matrix — sortable by strength/year, click Abstract to expand
Evidence Types
6
MECH 6CLIN 0GENE 0EPID 0
Claim
Stance
Category
Source
Strength ↕
Year ↕
Quality ↕
PMIDs
Abstract
NPTX2 consistently reduced in EC and CSF from prod…
Multi-persona evaluation:
This hypothesis was debated by AI agents with complementary expertise.
The Theorist explores mechanisms,
the Skeptic challenges assumptions,
the Domain Expert assesses real-world feasibility, and
the Synthesizer produces final scores.
Expand each card to see their arguments.
Gap Analysis | 4 rounds | 2026-04-22 | View Analysis
🧬TheoristProposes novel mechanisms and generates creative hypotheses▼
Mechanistic Hypotheses: Entorhinal Cortex Layer II Vulnerability in Alzheimer's Disease
Hypothesis 1: T-type Calcium Channel–Driven Calcium Overload and Proteostasis Collapse
Mechanism: Layer II stellate cells exhibit intrinsic regenerative firing properties driven by T-type (Cav3.2) calcium channels that produce low-threshold plateau potentials and rhythmic bursting at theta frequencies (~5 Hz). This generates sustained intracellular Ca²⁺ transients that chronically activate calpains, impair ubiquitin-proteasome function, and accelerate tau hyperphosphorylation at AD-relevant
🔍SkepticIdentifies weaknesses, alternative explanations, and methodological concerns▼
Critical Evaluation of Hypotheses on Entorhinal Cortex Layer II Vulnerability in Alzheimer's Disease
Specificity problem. T-type calcium channels (Cav3.2 and related subtypes) are expressed throughout the brain, including thalamic relay neurons, inferior olive cells, and other neuronal populations that do not show equivalent vulnerability in AD. If Cav3.2 upregulation is the primary driver, why are layer II stellate cells uniquely susceptible? The hypothesis does not adequately explain regional specificity—
🎯Domain ExpertAssesses practical feasibility, druggability, and clinical translation▼
Feasibility Assessment: Entorhinal Cortex Layer II Vulnerability Hypotheses in Alzheimer's Disease
Executive Summary
Of the seven proposed mechanisms for entorhinal cortex (EC) layer II vulnerability, four merit serious clinical development consideration based on druggability, biomarker readiness, and translational feasibility. The T-type calcium channel hypothesis (H1) and NPTX2 replacement (H6) represent the most near-term intervention opportunities given existing pharmacologic tools. The mTOR-autophagy axis (H7) offers a mechanistically distinct but overlapping target with rapamycin-
⚖SynthesizerIntegrates perspectives and produces final ranked assessments▼